Evidence map›Paper›PMID 24496006›Full record

ArticleScientific reports2014

Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma.

Claudia Pfitzner, Isabel Schröder, Cornelia Scheungraber, Askin Dogan, Ingo Bernhard Runnebaum, Matthias Dürst, Norman Häfner

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Single-Cell Analysis of BRAFMethods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Aneuploid CTC and CEC.Diagnostics (Basel, Switzerland) · 2018
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claudia PfitznerDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Isabel SchröderDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Cornelia ScheungraberDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Askin DoganDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Ingo Bernhard RunnebaumDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Matthias DürstDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Norman HäfnerDepartment for Gynaecology and Obstetrics, Jena University Hospital, Friedrich Schiller University, Germany.
Friedrich Schiller University Jena · DEJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of circulating tumour cells (CTC) in cancer patients may be useful for therapy monitoring and prediction of relapse. A sensitive assay based on HPV-oncogene transcripts which are highly specific for cervical cancer cells was established. The Digital-Direct-RT-PCR (DD-RT-PCR) combines Ficoll-separation, ThinPrep-fixation and one-step RT-PCR in a low-throughput digital-PCR format enabling the direct analysis and detection of individual CTC without RNA isolation. Experimental samples demonstrated a sensitivity of one HPV-positive cell in 500,000 HPV-negative cells. Spike-in experiments with down to 5 HPV-positive cells per millilitre EDTA-blood resulted in concordant positive results by PCR and immunocytochemistry. Blood samples from 3 of 10 CxCa patients each contained a single HPV-oncogene transcript expressing CTC among 5 to 15*10(5) MNBC. Only 1 of 7 patients with local but 2 of 3 women with systemic disease had CTC. This highly sensitive DD-RT-PCR for the detection of CTC may also be applied to other tumour entities which express tumour-specific transcripts.

Indexed as

Neoplastic Cells, CirculatingBiomarkers, TumorCell Line, TumorDNA-Binding ProteinsDNA, ViralFemaleHeLa CellsHuman papillomavirus 16Human papillomavirus 18HumansOncogene Proteins, ViralRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionUterine Cervical NeoplasmsBiomarkers, TumorDNA-Binding ProteinsDNA, ViralE6 protein, Human papillomavirus type 16E6 protein, Human papillomavirus type 18Oncogene Proteins, ViralRepressor Proteins

Identifiers

PMID24496006
PMCPMC3913920
OpenAlexW2000253644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.